Breaking Finance News

Greenlight Capital Re, Ltd. (NASDAQ:GLRE) has been downgraded to Strong Sell in a statement by Zacks Investment Research earlier today.

Yesterday Greenlight Capital Re, Ltd. (NASDAQ:GLRE) traded 0.30% lower at $20.03. GLRE’s 50-day average is $20.80 and its two hundred day average is $20.68. The last stock close is down 3.34% relative to the 200-day moving average, compared to the Standard & Poor’s 500 Index which has decreased -0.01% over the same time period. Trade volume was was down over the average, with 50,919 shares of GLRE changing hands under the typical 115,534 shares..

Zacks Investment Research has downgraded Greenlight Capital Re, Ltd.(NASDAQ:GLRE) to Strong Sell in a statement released 9/19/2016.

Performance Chart:

Greenlight Capital Re, Ltd. (NASDAQ:GLRE)

Greenlight Capital Re, Ltd. has a one-year low of $16.05 and a 52 week high of $25.20 . The company’s market cap is presently $0.0.

Brief Synopsis About Greenlight Capital Re, Ltd. (NASDAQ:GLRE)

Greenlight Capital Re, Ltd. is a property and casualty reinsurance holding company. The Company operates through property and casualty reinsurance segment. Its underwriting operations are classified into two categories: frequency business, which is characterized as contracts containing a number of small losses emanating from multiple events, and severity business, which is characterized as contracts with the potential for losses emanating from one event or multiple events. The Company’s property line of insurance provides protection for aviation, commercial, energy, motor physical damage and personal. It offers casualty insurance products for general, marine, motor and professional liabilities. The Company’s specialty insurance products are offered for financial, health and worker’s compensation. Its subsidiaries include Greenlight Reinsurance, Ltd, (Greenlight Re), Greenlight Reinsurance Ireland, Ltd. (GRIL) and Verdant Holding Company, and Ltd. (Verdant).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *